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a b s t r a c t
The correct folding, heterodimerization and trafﬁcking of Gn/Gc envelope glycoproteins of Rift Valley
fever virus, RVFV (Bunyaviridae and Phlebovirus genus) are essential for Golgi assembly and budding
of viral particles. The Gn and Gc carboxy-terminus contain a Golgi targeting and an ER-retrieval signal,
respectively. We generated RVFV-like particles with mutations in the cytosolic tails of Gn or Gc and
identiﬁed regions important for release of infectious particles. The role of speciﬁc amino-acids in these
regions was further investigated by creating recombinant mutant viruses by reverse-genetics. Residues
outside the suspected Golgi targeting motif, i.e. the di-lysine K29-K30 motif and the N43, R44 and I46
residues of the Gn cytosolic domain, appeared important for Golgi localization and RNP packaging.
Concerning the Gc tail, replacement of K2 or K3 in the di-lysine motif, had a drastic impact on Gn
trafﬁcking and induced an important organelle redistribution and cell remodeling, greatly affecting
particle formation and release.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Rift Valley fever (RVF) is a mosquito-borne emerging zoonosis
caused by a Phlebovirus of the family Bunyaviridae (Plyusnin et al.,
2011). RVF virus (RVFV) is endemic in sub-Saharan African coun-
tries and has progressively extended its territory to Egypt, Mada-
gascar, the Arabian Peninsula (Bird et al., 2009; Pepin et al., 2010)
and more recently the Comoros Islands (Cêtre-Sossah et al., 2012,
Roger et al., 2011). In h$numbers 1fdeumans, RVFV infection leads
to a broad range of clinical symptoms, from asymptomatic to fatal
hepatitis with hemorrhagic syndrome. In domestic ruminants, the
disease is most severe in newborns and in pregnant animals
causing respectively a high rate of mortality and abortion
(Gerdes, 2004) and raising considerable economic problems in
endemics countries (Chevalier et al., 2010).
RVFV is an enveloped tri-segmented RNA virus of negative
(L and M) or ambisense (S) polarity (Plyusnin et al., 2011; Plyusnin
and Elliott, 2011). The L and M segments code respectively for
the RNA dependent RNA polymerase (Muller et al., 1994) and for
a polyprotein precursor, which is cleaved in the endoplasmic
reticulum (ER) to generate the envelope glycoproteins, Gn and
Gc (Collett et al., 1985; Suzich et al., 1990). Processing of the
polyprotein also gives rise to two nonstructural proteins NSm1
and NSm2 (Gerrard and Nichol, 2007). The S segment codes for
two proteins in opposite polarities: the 5′ half of the genomic and
antigenomic RNA encoding the nonstructural protein, NSs, and the
nucleoprotein, N, respectively (Giorgi et al., 1991).
As a characteristic feature of bunyaviruses, viral particle assembly
takes place at the Golgi complex inside cisternae where virions have
been shown to bud (Pettersson and Melin, 1996; Schmaljohn and
Nichol, 2007). This process is initiated by the accumulation of the
envelope glycoproteins, Gn and Gc, in the Golgi apparatus, followed
by the recruitment of the nucleoprotein, N in this same region. Since
bunyaviruses do not express any matrix protein, it is assumed that
N is recruited in the vicinity of the Golgi through its interaction with
the cytosolic tails of the envelope glycoproteins, allowing ribonu-
cleoproteins (RNP) encapsidation during particle assembly (Hepojoki
et al., 2010; Overby et al., 2007a; Strandin et al., 2011). The cytosolic
tail of Gn is also involved in Golgi targeting and retention of the
Gn/Gc heterodimers constituting the viral spikes (Andersson and
Pettersson, 1998; Lappin et al., 1994; Overby et al., 2007b; Persson
and Pettersson, 1991; Pettersson et al., 1995; Shi and Elliott, 2002; Shi
et al., 2007, 2004). Indeed, upon cotranslational processing of the
M segment-encoded polyprotein, the Gn and Gc glycoproteins transit
from the ER to the Golgi (Gerrard and Nichol, 2002; Matsuoka et al.,
1994) due to the presence of a Golgi targeting signal located within
the Gn C-terminal sequence. In contrast, Gc remains in the ER when
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expressed alone (Gerrard and Nichol, 2002). A basic di-lysine motif
(KKXX-COOH), conserved among phleboviruses but not present in all
bunyavirus genera, is found in the short C-terminal domain of Gc and
may account for its ER retention in absence of Gn (Overby et al.,
2007b). These data have led to the assumption that Gc is transported
to the Golgi only upon interaction with Gn acting as a chaperone in
this process.
In spite of the recognized involvement of the Gn cytosolic
tail in virus maturation and budding (Strandin et al., 2013), no
consensus motif has been identiﬁed so far for Golgi targeting or
RNP encapsidation. However, various signals have been described
depending on the bunyavirus genus and the expression system
used for analysis. In the particular case of phleboviruses, the non-
pathogenic Uukuniemi virus (UUKV) model is well documented. In
contrast, data on the highly pathogenic RVFV, which requires high
biosafety containment, are more limited and mainly rely on the
expression of recombinant glycoproteins (Gerrard and Nichol,
2002, 2007; Kakach et al., 1989; Schmaljohn et al., 1989; Suzich
et al., 1990). Among the three most studied phleboviruses, UUKV,
RVFV and Punta Toro virus, signals for Golgi targeting vary (Fig. 1):
it depends on 40 amino acids (residues 10–50) located in Gn
cytosolic tail for UUKV (Andersson et al., 1997), on the whole
transmembrane domain and the following 10 amino acids of Gn
for the Punta Toro virus (Matsuoka et al., 1994, 1996), while in
RVFV, the 20 amino acids terminal to the transmembrane domain
of Gn and 28 contiguous residues appeared to be sufﬁcient
(Gerrard and Nichol, 2002). One explanation for these differences
could be the low degree of conservation in the sequences of the Gn
cytosolic tails (Gerrard and Nichol, 2002).
Virus-like particles (VLPs) are infectious but non-pathogenic and
highly antigenic (Habjan et al., 2009; Mandell et al., 2010; Naslund
et al., 2009). This strategy has been particularly useful to decipher
the role of speciﬁc motifs and residues of Gn and Gc in the
morphogenesis and release of UUKV (Overby et al., 2006, 2007a,
2007b). VLPs have only been recently exploited to study RVFV
genome packaging (Piper et al., 2011; Terasaki et al., 2011).
Concerning the Gn cytosolic tail of RVFV, the results differ from
those obtained with UUKV glycoproteins. In particular a RNP
binding site has been assigned to the 76–81 terminal sequence of
UUKV Gn cytosolic tail while a corresponding sequence does not
exist in the RVFV Gn protein which is only 71 amino acids long (see
Fig. 1). It has been suggested that the ﬁrst 30 amino acids of RVFV
Gn cytosolic tail could interact with N, while the RdRp interacting
region would involve downstream residues (Piper et al., 2011). In
the present study, we combined the VLP-based methodology and
virus rescue by reverse genetics to better characterize motifs in the
cytosolic tails of RVFV glycoproteins involved in particle formation.
This strategy allowed us to identify residues playing critical roles for
ER to Golgi transport and virus budding. In particular, this work has
highlighted the impact of some mutations on intracellular trafﬁck-
ing and compartment remodeling in mammalian cells infected with
recombinant mutant viruses.
Results
Identiﬁcation of speciﬁc sequences in Gn and Gc cytosolic tails
important for trafﬁcking and release of RVFV-like particles
A RVFV-VLP system was established using the murine Pol-I based
L-segment plasmid expressing a CAT minigenome and plasmids
expressing the viral structural proteins: L and N needed to reconstitute
RNPs (Gauliard et al., 2006) and Gn and Gc envelope glycoproteins.
The cells transfected by these plasmids (also called VLP producers) are
expected to release infectious VLPs in the medium.
In authentic RVFV infected cells, synthesis of the glycoprotein
precursor is initiated at one of the ﬁve in frame AUG codons
leading to the expression of overlapping polyproteins (Collett
et al., 1985). Initiation at the ﬁrst two AUG codons, located at the
N terminus of the precursor, leads to synthesis of the NSm1 and
NSm2 non-structural proteins in addition to the structural envel-
ope glycoproteins. The fourth AUG, located just upstream of the Gn
signal peptide, gives rise to Gn and Gc only. In order to avoid
expression of NSm proteins known to be dispensable for the viral
cycle (Gerrard et al., 2007; Won et al., 2006), we chose to express
the envelope glycoproteins from the fourth AUG codon (Fig. 2A).
In VLP producer cells, the minigenome replicated efﬁciently
and CAT expression was even higher in the presence of glycopro-
teins that likely facilitated dissemination of infectious particle
to neighboring cells (not shown). The polyprotein encoded by the
pTM1-Gn–Gc plasmid was indeed efﬁciently processed into Gn
and Gc (Fig. 2B, lane 1), which localized at the Golgi complex, as
expected (Fig. 2D). Protein analysis of semi-puriﬁed wild type
(WT) VLPs, performed under non-reducing conditions to preserve
conformational epitopes, showed that Gn migrated as a unique
band and Gc as a doublet possibly due to variable occupancy of its
N-glycosylation sites (Fig. 2B, lane 1).
To monitor the presence of infectious VLPs, the supernatant of
VLP producer cells was used to infect helper cells (which express
only the L and N proteins for efﬁcient minigenome replication) and
the minigenomes packaged into the infecting VLPs will generate
the reporter CAT activity as described (Habjan et al., 2009). Indeed,
when a complete set of plasmids expressing the glycoproteins and
the L and N proteins was co-transfected in VLP producer cells, VLPs
were efﬁciently released in the medium and were able to initiate
an infectious cycle in helper cells as assessed by CAT expression
(Fig. 2C, lane 1). The ability of VLPs to infect helper cells was
inhibited by anti-RVFV neutralizing antibodies as conﬁrmed by the
reduction in CAT activity (Fig. 2C, lane 1). Thus, our VLP system
appeared suitable for further analysis of viral morphogenesis.
The carboxy-terminal sequence of Gn contains a transmem-
brane domain followed by a region spanning over seventy residues
(Fig. 2A) from which the ﬁrst twenty eight amino acids have been
described to be part of a Golgi retention motif (Gerrard and Nichol,
2002); whereas the role of the other residues remains elusive.
The schematic representation in Fig. 2A also shows that Gc
Fig. 1. Schematic representation of Gn cytosolic domain of different Phleboviruses and their role in virus assembly. The amino acid sequences of Gn cytosolic tails for the
ZH548 strain of Rift Valley fever virus (RVFV), Uukuniemi virus (UUKV) and Punta Toro virus (PTV) were aligned as proposed by Gerrard and Nichols (2002). The numbering
begins at the ﬁrst amino-acid just following the hydrophobic transmembrane domain of Gn. The regions described to have a role in Golgi targeting, RNP binding domains
and the RdRP determinants are underlined in blue, red and green, respectively (Gerrard and Nichols, 2002; Piper et al., 2011; Andersson et al., 1997; Overby et al., 2007a,
2007b; Matsuoka et al., 1996). The residues mutated in recombinant RVFV and found to be involved in Golgi targeting or virus budding have been highlighted in blue and red,
respectively.
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terminates with a transmembrane domain followed by a short
cytosolic tail composed of only ﬁve residues that contain informa-
tion for ER retention (Overby et al., 2007b).
To assess the role of these domains in more details, we produced a
set of deletion mutants by serial removal of contiguous stretches of
7 residues (5 only in the case of Gc), in such a way to cover the entire
cytosolic tail of Gn and Gc (Fig. 2A). The impact of these deletions was
evaluated by testing VLP release and infectivity. VLPs with Gn
deletions encompassing amino acids 8–14, 50–56 and 57–63 were
produced as shown byWestern blot analysis of glycoproteins from VLP
Fig. 2. Effect of serial deletions covering the entire Gn or Gc cytosolic tails, on VLP maturation. (A) Position and numbering of the deletion introduced in the open reading
frame of the RVFV M segment beginning at the fourth AUG initiating codon are schematized. TM and SP correspond respectively to the transmembrane domains signal
peptides expected to be used for insertion into membranes of the secretory pathway. (B) Western blot analysis of Gn and Gc recovered from the supernatant of BHK-T7 cells
transfected by the set of plasmids required to produce minigenome based VLPs. The expressed glycoproteins are the wild type (lane 1) or deleted ones (lanes 2–11), as
indicated. On the right side of each gel, the lane ZH corresponds to the glycoprotein content of virus particles puriﬁed from ZH548 infected Vero E6 cell supernatant. The
histogram under the gels represents the Gc/Gn ratio in the different VLPs as compared to ZH viral particles used as internal control (ratio¼1). (C) Infectivity of VLPs released
in the supernatant of BHK transfected cells was tested after infection of helper cells and monitoring reporter CAT activity (black bar). As a control, supernatants containing
VLPs were pretreated with anti-RVFV neutralizing antibodies to speciﬁcally inhibit the activity (gray bar). The same numbering as in panel B is used: lane 1 corresponding to
wild type VLPs and lanes 2–11, to mutant VLPs with deletion in the Gn cytosolic tail. The additional lane 12 in (C) corresponds to VLPs produced with the Δ1–5 deletion in Gc
cytosolic tail. The deletions in Gn cytosolic tail (Δ22–28 and Δ43–49) and Gc cytosolic tail (Δ1–5) with the greatest impact on VLP release, identiﬁed with a red star in the
different panels, were further analyzed by immunoﬂuorescence for their impact on intracellular trafﬁcking (D). Subcellular localization in permeabilized ﬁxed cells was
assessed by merging glycoprotein staining (red) with ER or Golgi staining (green) using anti calnexin or anti giantin antibodies respectively. When co-localization occurs it
appears in yellow in the merge pictures. Scale bar corresponds to 10 μm.
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preparations and were infectious as measured by CAT activity detected
in helper cells (Fig. 2B and C, lanes 3, 9 and 10), as in the case of WT-
VLPs (lane 1). The relative amount of each glycoprotein was evaluated
by Western blot and the Gc/Gn ratio determined using puriﬁed virus
particles from the wild type ZH-548 strain as an internal reference.
One can notice that the ratio estimated for the mutants producing
infectious VLP GnΔ8–14 and GnΔ50–56 (lanes 3 and 9) was compar-
able (i.e. around 1:2) to those of the WT-VLPs but signiﬁcantly lower
1:10 for GnΔ57–63 (lane 10). We cannot exclude that the lack of NSm
proteins for VLP production could affect the maturation of the
glycoproteins and lead to reduced amounts of Gc in VLPs that could
also contribute to some variability. However, these data seem to
indicate that a high Gc/Gn ratio in the VLPs correlates with a
signiﬁcant infectivity measured by CAT activity on helper cells, the
level of which depends also on the amount of VLPs released. The other
deletions led to a drastic reduction in CAT activities, whether VLPs
were released or not. In particular, the GnΔ22–28 and GnΔ43–49
mutants exhibited almost no CAT activity and no viral glycoproteins in
the supernatant of transfected cells (Fig. 2B and C, lanes 5 and 8). An
intermediate situation was encountered with the Δ1–7, Δ15–21,
Δ29–35, Δ36–42, and Δ64–70 deletions in Gn cytosolic tail (lanes
2, 4, 6, 7 and 11 of Fig. 2B and C) where CAT activity was barely
detectable while viral glycoproteins were identiﬁed in VLPs, although
in reduced amounts. Beside variable quantities of VLPs produced
depending on the deletion, it is noticeable that in these latter mutants,
the Gc/Gn ratio was much lower than in WT-VLP, Gc being even
undetectable in GnΔ36–42 (lane 7).
The impact on intracellular localization of Gn and Gc of the
Gn-Δ22–28 and Gn-Δ43–49 deletions, both linked to an inability to
produce infectious VLPs, was further analyzed by co-immunostaining
with antibodies recognizing organelles from the secretory pathway.
As shown in Fig. 2D, the Δ22–28 mutation did not affect the
localization of Gn and Gc which were observed in the Golgi like
the wild type glycoproteins. On the other hand, in the case of the Gn-
Δ43–49 mutant, most of the viral glycoproteins co-localized with
calnexin, the ER marker, while only a small fraction was found in the
Golgi apparatus as compared with Gn-WT (Fig. 2D). This strongly
suggested that this deletion in Gn impeded the transit from ER to
Golgi, which likely resulted in a failure to produce infectious VLPs.
Unfortunately it was not possible to follow intracellular maturation
of the viral glycoproteins during VLPs assembly due to the low
efﬁciency of the system. None of the other deletions in the Gn
cytosolic tail associated with a reduced particle release, led to an
altered Golgi localization of the viral glycoproteins (data not shown)
indicating a possible defect in the particle budding process.
With regard to the short cytosolic tail of Gc (Fig. 2A), expression of
Gc-Δ1–5 was associated to a reduced production of VLPs and a low
CAT activity on helper cells (Fig. 2C, lane 12 and Fig. 3A, lane 18). This
mutation led to a lower production of VLPs thanWT Gc, as shown by
the reduced amount of Gn (Fig. 3B, lanes 17–18) but the Gc/Gn ratio,
close to 1 (lane 18) was similar to the one observed for RVFV
particles. Also, this Gc deletion led to an improper localization of the
viral glycoproteins mostly accumulating in the ER (Fig. 2D, lower
panels). The lower amounts of VLPs produced by the Gc-Δ1–5
mutant compared to wild type VLPs could be explained by a defect
in glycoprotein trafﬁcking either due to misfolding, incorrect assem-
bly or heterodimerization of Gc with Gn.
Taken together these data highlighted the crucial role of
speciﬁc regions in the cytosolic tails of Gn and Gc for infectious
particle morphogenesis.
Production of VLPs with single alanine substitution in Gn and Gc
cytosolic tails
We next attempted to deﬁne which of the residues in the
22–28 or 43–49 sequences of Gn and 1–5 sequence of Gc cytosolic
tails would be critical for particle budding and/or glycoprotein
trafﬁcking. Since the 22–28 sequence of the cytosolic tail of Gn is
immediately followed by a di-lysine motif that can be involved in
intracellular targeting, these two positions (K29 and K30) were
also included in our analysis. Except for the amino acids being
already an alanine (Gn-A22 and Gc-A5) or structurally not
substitutable (Gn-W26, W47 and W48), single alanine substitu-
tions were introduced in the pTM1-Gn–Gc plasmid and mutant
VLPs were then produced that covered residues 22 to 30 or 43 to
49 of Gn as well as 1 to 5 of Gc cytosolic tails.
Among residues 22–28 of Gn, the R25A, I27A, and Y28A
substitutions did not affect VLP release (Fig. 3A, lanes 6–8) as
compared to WT-VLPs (lane 1). Only the alanine substitution of the
F23 and I24 residues led to VLPs of reduced infectivity, as shown
by CAT activity in helper cells, together with a reduced amount of
Gn and Gc in the supernatant (Fig. 3A and B, lanes 4 and 5). In a
similar way, mutating the contiguous lysine residues K29 and K30
reduced the release of infectious particles (Fig. 3A and B, lanes
9 and 10). This was unlikely due to glycoprotein missorting since
in the context of these four mutations, Gn reached the Golgi
apparatus (data not shown). However, for the Gn-K29A and -K30A
mutants, the Gc/Gn ratio appeared to be close to the WT-VLPs but
was highly reduced for both Gn-F23A and -I24A. This suggested
that different mechanisms must operate for these mutations,
all leading to a reduction in VLPs production and infectivity.
The I20 and T21 residues upstream of this motif, which have been
demonstrated to be important for production of UUK VLPs (Overby
et al., 2007b), were also substituted by an alanine, but we did not
ﬁnd any impact of these mutations on RVFV-VLP release (Fig. 3A
and B, lanes 2 and 3).
Concerning residues 43 to 49 (Fig. 3A and B, middle panels),
with the exception of Gn-E45A (lane 14) behaving like WT-Gn of
ZH-548 viruses, the other point mutations, Gn-N43A, -R44A or
-I46A (lanes 12, 13 and 15), had a severe impact on VLP release and
infectivity. Golgi localization of these three Gn mutants was also
altered (Fig. 3C, left panel), in particular Gn-I46A accumulated to a
large extent in the ER in a similar way to Gn-Δ43–49 (Fig. 2D).
Of note, the triple mutation Gn-N43-R44-I46 referred to as NRI
(Fig. 3 A and B, lane 16) was sufﬁcient to fully abolish infectivity,
while VLPs were still produced as was also the case for GnΔ43–49
(compared Fig. 3, lane 16 with Fig. 2, lanes 8).
Additionally, alanine substitutions were introduced in the short
cytosolic tail of Gc (…TKKAS). As shown in Fig. 3 (right panels), the
Gc-T1A substitution led to release of infectious VLPs (Fig. 3A and B,
lane 21) and to Golgi localization at least equivalent to WT-VLPs
(Fig. 3C, Gc-T1A as compared to Fig. 2D, WT); whereas the K2A and
K3A mutations signiﬁcantly impaired VLP infectivity (Fig. 3A and
B, lanes 19 and 20) and led to an increased ER localization of the
mutated glycoproteins (Fig. 3C), which is reminiscent of Gc-Δ1–5.
It is therefore likely that the impaired VLP production was due to
an altered trafﬁcking of the envelope glycoproteins to the Golgi.
However, the fact that the Gc/Gn ratio is close to the one of the
WT-VLPs suggests a delay in trafﬁcking or in glycoprotein
heterodimerization.
These results point to an important role of the hydrophobic
phenylalanine F23, the isoleucine I24 and the basic lysine K29 and
K30 of the Gn cytosolic domain for efﬁcient release of infectious
VLPs. Other residues, such as N43, R44 and I46 of Gn or K2 and K3
of Gc also appeared to be crucial for trafﬁcking and budding of
infectious virus like particles.
Growth properties of recombinant RVFV mutant viruses with alanine
substitutions in Gn and Gc cytosolic tails
The VLP system allowed us to delineate speciﬁc sequences
playing a role in VLP infectivity and particle release. However, this
X. Carnec et al. / Virology 448 (2014) 1–144
study was limited by a low efﬁcacy of VLP reconstitution in BHKT7
together with the fact that the N protein was found in the
supernatant of transfected cells even in the absence of viral
glycoproteins (data not shown), as observed recently (Kortekaas
et al., 2011). In addition, although it has been described that NSm
proteins are not required for virus replication in vitro, the Nsm1
protein (78 kDa) is present in mature viruses (see ZH migration at
the right side of each blot in Figs. 2 and 3B) and could have a yet
unrecognized impact on VLPs maturation as for instance the reduced
Gc/Gn ratio observed for WT-VLPs. We therefore assessed the impact
of the selected mutations in the context of a fully infectious RVFV,
using a reverse genetic system (Billecocq et al., 2008). The alanine
substitutions identiﬁed as causing a drastic effect on VLP production
— i.e. F23A, I24A, K29A, K30A, N43A, R44A and I46A for Gn and K2A
Fig. 3. Determination of speciﬁc residues in the 20–30 and 43–49 regions of Gn cytosolic tail and 1–5 of Gc cytosolic tail important for VLPs release. The same experimental
approaches as in Fig. 1 was used to evaluate (A) the release of infectious VLPs by monitoring the CAT activity in helper cells, without (black bar) or with (gray bar) a
pretreatment by neutralizing antibodies, (B) the Gn and Gc content of secreted VLPs by immunoblot analysis and (C) intracellular localization of the mutated glycoproteins by
immunoﬂuorescence microscopy analysis upon co-staining with the giantin Golgi marker. Left panels in (A and B) show the results obtained with single alanine replacement
of each residue of the 20–30 amino acid sequence of Gn, while the middle panels correspond to substitutions in the Gn 43–49 sequence and the right panels to mutants of
the Gc1–5 sequence as indicated. The histogram representing Gc/Gn ratio was obtained as described in Fig. 2. VLPs were produced with WT (lanes 1, 11, and 17) and mutated
glycoproteins (lanes 2–10, 12–16 and 18–21). In (C) only some of the mutant glycoproteins altered in their intracellular localization, i.e. Gn-N43A, -R44A, I46A (left panel) and
Gc-K2A and -K3A as compared to the unaffected Gc-T1A mutant glycoproteins (right panel), are shown.
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and K3A for Gc — were introduced into the pPol-I M plasmid. Once
rescued, recombinant RVFVs bearing speciﬁc mutations in Gn or Gc
within the ZH548 backbone were further studied for their growth
properties in Vero E6 cells and their protein composition was
analyzed by Western blot (Fig. 4).
First of all, it should be noted that it was not possible to rescue
viruses with a Gn-I46A mutation, consistent with the fact that
infectious VLPs carrying this mutation were not produced. Apart
from it, all the other single alanine substitutions mentioned above
led to viable recombinant viruses. Some of the mutations leading
to different behavior between VLPs and virus rescue will be
discussed later (see Discussion).
The growth properties of the mutated recombinant viruses
were determined by infecting Vero E6 cells at a m.o.i. of 1 and
collecting samples at different times post-infection. In contrast to
the corresponding VLPs, the ZH-Gn-F23A virus replicated efﬁ-
ciently and exhibited a growth curve similar to rescued wild type
virus, ZH-WT (Fig. 4A, upper panel). Nevertheless, we observed a
reduction of infectivity upon thawing, which could reﬂect instability
of the ZH-Gn-F23A particles (data not shown). This could explain the
more drastic effect observed in the VLP system where particles were
produced but were not able to infect helper cells. All the other
mutants were attenuated as shown by reduced virus production, the
least affected being the I24A mutant. The four other recombinant
viruses, ZH-Gn-K29A, -K30A, -N43A and -R44A grew with titers
almost 10 fold lower than ZH-WT, the bigger discrepancy being
observed with ZH-Gn-R44A (Fig. 4A, upper panel). The ZH-Gc-K2A
and -K3A recombinant RVFV mutants were also severely affected in
their growth as the viral yield was reduced by about 2 logs for ZH-
Gc-K3A when compared to ZH-WT (Fig. 4A, lower panel). Not only
was the titer of the reconstituted viruses affected but also their
plaque phenotype (Fig. 4B). In particular, while ZH-WT exhibited
large plaques, the K2A and K3A mutations in Gc cytosolic tail and
N43A and R44A in Gn cytosolic tail gave rise to smaller plaques.
It was also the case for ZH-Gn-I24A even though its titer was only
slightly reduced. Interestingly, the ZH-Gn-K29 and -K30 viruses
Fig. 4. Characterization of recombinant mutant viruses with single amino acid substitution. (A) growth properties of recombinant viruses carrying either wild type or
alanine substituted glycoproteins at F23, I24, K29, K30, N43 and R44 positions of Gn cytosolic tail (upper panel) or at K2 and K3 positions of Gc cytosolic tail (lower panel).
Viral titers measured as plaque forming units per mL (pfu/mL) were determined by plaque assay at different times post-infection in Vero E6 cells infected at a multiplicity of
infection of 1 with the different mutant viruses (color codes are indicated on the graph) or the ZH-WT virus as a control (black curve). (B) aspect of the plaques formed in
Vero cells infected with the indicated ZH-Gn (upper panel) and ZH-Gc mutant viruses (lower panel). The major structural proteins, Gn, Gc and N in virus particles were
analyzed by Western blotting (C). The ratio between the envelope glycoproteins and the nucleoprotein N was quantiﬁed using an ImageJ program and a representative
experiment is shown in (D). The histogram represents the Gc/Gn (black bar), Gn/N (gray bar), and Gc/N (white bar) ratios obtained for each mutant viruses.
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exhibited a mixed plaque phenotype (large and small plaques). It was
striking that ZH-Gn-F23A also, yielding high titer viruses, exhibited
such a phenotype.
The protein composition of puriﬁed viruses was analyzed by
Western blot using standardized amount of Gn to compensate
variations in the viral titers. The three major structural proteins Gn,
Gc and N were present in virus particles (Fig. 4C), but their ratio
signiﬁcantly varied depending on the mutation (Fig. 4D). While the
ZH-Gn-F23A and -I24A mutant viruses had a protein composition
similar to ZH-WT, the ZH-Gn-K29A, -K30A and to a lesser extent
-N43A recombinant viruses reproducibly showed a higher Gn/N
ratio, evocative of a defect in nucleoprotein recruitment by Gn
cytosolic tail. In contrast, the Gc-K2A and -K3A mutations led to
efﬁcient encapsidation as suggested by their G/N ratio similar to ZH-
WT. However, the ratio between the two glycoproteins Gc/Gn was
quite reduced in ZH-Gc-K3A mutant viruses.
These results obtained with rescued RVFV mutant viruses
reinforced the data obtained with VLPs and emphasized the role
of particular residues of the cytosolic tails of Gn and Gc on viral
particle morphogenesis thereby affecting the virus cycle.
Intracellular localization of the envelope glycoproteins in cells
infected with recombinant RVFVs carrying alanine substitutions in Gn
and Gc cytosolic tails
In an attempt to determine whether inefﬁcient recombinant
virus production related to a defect in trafﬁcking, assembly or
budding, we checked by immunoﬂuorescence microscopy the co-
localization of envelope glycoproteins with markers of different
cell compartments. In addition to its predominant Golgi localiza-
tion, Gn was also found in the ER of cells infected with the wild
type ZH548 virus, which can be expected for proteins produced at
high concentration and transiting by the secretory pathway.
Depending on the mutation in the Gn cytosolic tail, mutant
viruses exhibited overt differences when compared to the wild
type, with the exception of ZH-Gn-F23A (Fig. 5) and -I24A (data
not shown) viruses. In particular, the K29A mutation led to
cytoplasmic accumulation of Gn (Fig. 5A and B) which partly
colocalized with calnexin. In cells infected with ZH-Gn-K30A,
-N43A and -R44A mutant viruses, Gn formed massive aggregates
accumulating in the Golgi (Fig. 5A, B and not shown), thus
enlarging this organelle. Of note, Gn immunostaining exhibited a
substantial overlap with the ERGIC marker as observed in cells
infected with ZH-WT and the mutant viruses, ZH-Gn-F23A, -K29A,
-K30A, -N43A (Fig. 5C), suggesting a contribution of this compart-
ment in virus maturation.
Regarding mutations that affect the Gc tail, direct analysis of the
protein was refrained by the fact that our anti-Gc antibody solely
recognized the correctly folded Gc. Since Gn and Gc are supposed to
cooperate during trafﬁcking and particle assembly, we investigated
whether mutations in the di-lysine motif of Gc cytosolic tail also
had an impact on the localization of Gn. Strikingly, in Vero E6 cells
infected with ZH-Gc-K2A or -K3A recombinant viruses, Gn staining
was intense and its localization was greatly affected. Although Gn
was found together with markers of different cell compartments it
showed an atypical distribution all over the cells. In particular, while
Golgi labeling with anti-giantin antibodies was faint but character-
istic of a Golgi organization as compared to non-infected cells, large
aggregates of Gn overloaded this organelle (Fig. 6A, upper panels),
which probably reduced the accessibility of giantin epitopes to
antibodies. Gn colocalized with the markers of the ER (Fig. 6A,
middle panels) and ERGIC (Fig. 6A, lower panels) in cells infected
with both ZH-Gc-K2A and -K3A mutant viruses. However, these
compartments displayed unusual phenotype as compared to their
aspect in uninfected cells, indicative of drastic cell remodeling.
Surprisingly, Gn was also found at the cell periphery, close to the
plasma membrane (Fig. 6A). This latter point was illustrated by the
intense Gn staining observed at the cell surface of non-permeabilized
ﬁxed cells infected with ZH-Gc-K2A and -K3A as compared to the
punctuate membrane ﬂuorescence obtained with ZH-WT (Fig. 6B,
upper panels). Since the Gc-K2A or -K3A mutations led to a
mislocalization of Gn, we also carried out immunostaining of the N
nucleoprotein, normally recruited at the Golgi site of virus assembly.
In permeabilized ZH-WT infected cells, the granular cytoplasm
staining was reinforced in a perinuclear area that could indeed
correspond to the Golgi. In contrast, N was excluded from this area
in ZH-Gc-K2A and -K3A infected cells, but the labeling increased at
the cell periphery (Fig. 6B, lower panel). This is in accordance with
the ﬁnding that Gc-K2A and -K3A mutations affect Gn trafﬁcking and
lead to a complete remodeling of infected cells. Most notably, ZH-Gc-
K2A and -K3A infected cells displayed long ﬁlopodia structures
labeled with the anti-Gn antibody (Fig. 6).
The differences of intracellular location of the viral glycopro-
teins depending on speciﬁc mutations in Gn or Gc point out an
important role of their cytosolic tails not only on glycoprotein
trafﬁcking but also on reorganization of cell compartments.
Fig. 5. Intracellular localization of Gn in Vero E6 cells infected with recombinant viruses with mutation in Gn cytosolic tail. Immunoﬂuorescence assay was performed on
ﬁxed and permeabilized Vero E6 cells stained with anti Gn (in green) and with either anti giantin (A), anti calnexin (B) or anti ERGIC-53 antibodies (in red) (C), to determine
Golgi, ER, and ERGIC localization of Gn respectively. Individual and merge staining of infected cells is illustrated for wild type or mutant viruses carrying different Gn alanine
substitutions, as indicated.
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Residues K2 and K3 of the lysine motif in the Gc cytosolic tail play an
important role in cell remodeling
Together, these data led us to explore the effect of ZH-Gc-K2A
and -K3A viral infection on the cytoskeleton of Vero E6 cells by
ﬁrst investigating actin organization. As a control, immunoﬂuor-
escence triple labeling of the Golgi in blue, actin in red and Gn in
green as well as the merge picture was performed for wild type ZH
infected cells (Fig. 7A). Compared to non-infected cells (Fig. 7B;
NI), virus infection led to disruption of actin ﬁbers, which was
observed for WT-ZH infected cells as well as cells infected with
ZH-Gn-F23A, ZH-Gn-K29A and ZH-Gn-N43A, as shown in Fig. 6B
where triple staining was juxtaposed. Of note, a more drastic effect
was reproducibly observed with ZH-Gc-K2A and ZH-Gc-K3A
(Fig. 7B). Clearly, this emphasized a major impact of mutating
the dibasic motif of Gc on cortical actin remodeling as reproducibly
observed with these two mutants. Again, Gn was observed in the
long ﬁlopodia induced in ZH-Gc-K2A and -K3A infected cells while
Gnwas concentrating at the ER or Golgi compartments in ZH-WT or
the other recombinant viruses with mutation in Gn cytosolic tail.
Co-immunostaining of Gn and other cytoskeleton components
was then performed in cells infected with ZH-Gc-K3A and com-
pared to ZH-WT and two other prototypes of recombinant viruses:
ZH-Gn-F23A which, like ZH-WT replicated with a high titer in
Vero cells and ZH-Gn-N43A leading to an important accumulation
of Gn in the Golgi apparatus (representative of ZH-Gn-K30A and
-R44A). As illustrated in Fig. 8, actin ﬁlaments, microtubules
(tubulin) and intermediate ﬁlaments (vimentin) were differen-
tially affected by recombinant viruses. While tubulin remained
unchanged, except in the case of ZH Gc-K3A, or even stabilized as
seen in the case of ZH Gn-N43A, in infected versus non-infected
cells, actin stress ﬁbers were disrupted and the cortical actin
staining appeared more intense. Besides, vimentin ﬁlaments
appeared disorganized at the level of the microtubule-organizing
center and the amount of vimentin detected by immunoﬂuores-
cence was considerably increased in cells infected with mutant
viruses as compared to non-infected cells. Interestingly, Gn co-
localized with vimentin in Vero cells infected with all three types
of recombinant viruses, and a complete superimposition of the
large Gn aggregates with vimentin was observed in ZH-Gn-N43A
infected cells. Consistent with the other observations, ZH-Gc-K3A
infected cells were completely remodeled and showed long
cellular extensions speciﬁcally found in the rescued viruses with
mutation in the dilysine motif of the Gc cytosolic tail. Inserted
pictures (Fig. 8, lower panels) illustrate the distribution of Gn with
the different microﬁlaments in the ﬁlopodia-like structures of ZH-
Gc-K3A infected Vero E6 cells. It showed that Gn was wrapped
around a central cable of vimentin. Tubulin also localized at the
interior of the Gn stained structure while cortical actin appeared at
the periphery of the ﬁlopodia.
Altogether these results highlighted the role of the K2 and K3
lysine of the short Gc cytosolic tail for the correct addressing of
RVFV glycoproteins to the Golgi. This also pointed to an unex-
pected role of the Gc cytosolic tail on Gn trafﬁcking and possibly
on interaction with cytoskeleton components required for virus
assembly and impacting the cellular organization.
Discussion
The aim of the present work was to determine the contribution
of residues located in the cytosolic tails of Gn and Gc glycoproteins
to RVFV particles trafﬁcking, assembly and release. Two regions at
positions 20–30 and 43–49 in Gn C-terminus and the short Gc
cytosolic tail appeared crucial for production of infectious RVFV
Fig. 6. Localization of Gn in Vero E6 cells infected with recombinant viruses with
mutation in Gc cytosolic tail. Using the same procedure as described in Fig. 4,
intracellular co-localization of Gn (in green) (A) with either Golgi (giantin), ER
(calnexin) or ERGIC (ERGIC-53) markers (in red) was studied for recombinant viruses
with mutation in the dilysine motif of Gc as compared to the aspect of the organelles
in non-infected cell cultures. Individual and merge staining are shown for ZH Gc-K2A
and -K3A. (B) shows localization of Gn at the cell surface of non-permeabilized ﬁxed
Vero E6 cells and the intracellular distribution of the nucleocapsid in permeabilized
ﬁxed cells infected with ZH-Gc-K2A and -K3A mutant viruses as compared to ZH-WT.
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virus-like particles. Single substitutions were introduced in these
sequences to generate mutants, both RVFV-VLPs and recombinant
viruses and have highlighted the absolute requirement of the Gn-
I46 residue for virus reconstitution and the role of the polar amino
acids, K29, K30, N43 and R44 of Gn and K2 and K3 of Gc, in
different aspects of particle morphogenesis and cellular remodel-
ing. Some discrepancies were observed between VLPs and recom-
binant viruses; for instance, different mutations in Gn or Gc
impeded completely or partially infectious particle formation
while recombinant viruses were produced. We think that the
absence of NSm proteins during VLP reconstitution and the use of
an EMCV IRES for the expression of the recombinant viral proteins
may account for the differences observed. Also the context of
cotransfection for the production of infectious VLPs is quite
different from those of complete viral cycles where viral protein
synthesis is highly regulated in time and space. However, it should
be noted that except for the I46A mutation which had a drastic
effect on virus rescue, all the other mutations led to some
alterations at least in the plaque phenotypes, even when virus
growth was not signiﬁcantly affected.
Several conclusions can be drawn from our genetic analysis
on the role of the cytosolic domains of the RVFV glycoproteins in
particle assembly and release. Deletions covering regions 22–28
and 43–49 of Gn cytosolic tail impaired the release of infectious
VLPs also shown for UUKV (Overby et al., 2007b). Alanine
substitutions revealed the implication of F23 and I24 residues in
this process without affecting Golgi targeting. A similar role of the
L23 and L24 amino acids has been described in early events of UUK
virus like particle budding (Overby et al., 2007b), while other data
on RVFV glycoproteins suggests that the F23 and I24 residues
reside within a Golgi targeting signal (Gerrard and Nichol, 2002).
Noteworthy, the Gn-K29A or K30A single mutation just adjacent to
this previously characterized Golgi targeting motif exhibited a
reduced infectivity in our helper cell system. Moreover, the N43,
Fig. 7. Actin remodeling induced by mutant viruses in Vero E6 infected cells. The pictures in (A) show details of intracellular staining of the Golgi (dark blue), actin (red) and
Gn (green) and of merging the three color staining in permeabilized Vero E6 cells infected with the ZH-WT virus as a control. The colocalization of the Golgi marker with Gn,
appears in light blue and when occurring with actin (see ZH Gn-N43A), in purple. Although actin stress ﬁbers were disrupted in ZH-WT infected cells, no colocalization of Gn
with actin that should appear in yellow was visible in these cells. (B) Vero E6 cells infected with mutant viruses ZH-Gn-F23, -K29, -N43 and ZH-Gc-K2 or -K3 and compared
to non-infected cells (NI). Only the merge results of the triple labeling are represented.
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R44 and I46 residues, also located outside of the previously identiﬁed
RVFV Golgi targeting and retention signal, were shown here to be
important for Golgi localization and thus for release of VLPs as
indicated by an accumulation of the mutated glycoproteins in the ER.
These differences may be due to the different expression systems
utilized in the analysis: in our study we used the authentic
glycoprotein to express VLPs while Gerrard and coll. expressed a
chimera consisting of a GFP protein fused to the RVFV transmem-
brane domain and 28 C-ter adjacent amino acids. However, we
cannot exclude that in our VLPs system the ER accumulation of
mutated Gn resulted from altered folding or assembly of the Gn–Gc
heterodimer leading to a delay in trafﬁcking to the Golgi.
To circumvent the problem linked to expression system, we
reconstituted RVFV viruses in order to investigate the effect of VLP
selected mutations in the context of a full and efﬁcient virus cycle.
The F23A and I24A mutations did not signiﬁcantly alter the virus
growth cycle in comparison to wild type ZH548, differences only
residing in plaque aspects and viral titer waning over time. We
speculate a structural implication of these residues on particle
stability, which could also affect virus re-entry and account for the
non-infectivity of the corresponding VLPs. In contrast, the growth
properties of ZH-Gn-K29A or -K30A viruses were greatly affected.
Their viral titers were reduced to approximately 28% compared to
ZH-WT and their higher G/N content suggested a defect in RNPs
packaging. This correlated with intracellular accumulation of
Gn-K29A and -K30A in infected cells, which could reﬂect a delay
in Gn/Gc trafﬁcking or a tendency of these glycoproteins to be
retained in the ER and/or Golgi. Concerning residues 43–49 of the
Gn cytosolic tail, our data conﬁrmed the importance of N43, R44
and I46 for proper Golgi localization, viral assembly and particle
release: (i) it was not possible to rescue any ZH-Gn-I46A mutant
viruses and (ii) the N43A and R44A substitutions had a strong
impact on virus replication as indicated by a reduction in ZH-Gn-
N43A and -R44A viral titers (respectively 27% and 8% the one of
ZH-WT) and by smaller plaques. The altered RNPs content of ZH-
Gn-N43A viral particles could indicate a defect in packaging. Huge
aggregates of Gn-N43A and -R44A in the Golgi of infected cells
may also reﬂect a defect in assembly leading to accumulation of
viral components. Since genetic (Overby et al., 2007a) and struc-
tural studies (Huiskonen et al., 2009) strongly suggest that viral
RVFV envelope glycoproteins physically interact with RNPs, it
would be of interest to further determine whether the K29, K30
Fig. 8. Impact of recombinant mutant viruses on the cytoskeleton of E6 infected cells. Immunoﬂuorescence analysis of different components of the cytoskeleton (in red) and
of Gn (in green) in permeabilized cells infected with three representative types of mutant viruses (ZH-Gn-F23A, -Gn-N43A and -Gc-K3A) as compared to the cytoskeleton of
non-infected cells (NI) and ZH-WT infected cells. Distribution of Gn with the actin microﬁlaments is shown in the left panels, with the tubulin microtubules, in the middle
panels and with the intermediate ﬁlaments of vimentin, in the right panels. Colocalization indicated by a yellow staining was only visible for the co-staining of Gn and
vimentin. Of note, the K3A substitution in the Gc cytosolic tail induced important cell remodeling. Magniﬁed details of ﬁlopodia-like structures are shown in inserts in the
lower panels corresponding to ZH-Gc-K3A infected cells.
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or N43 and R44 polar residues of Gn cytosolic tail could interact
with N. Our analysis of the Gn cytosolic tail was limited to
sequences of greatest impact on release of infectious VLPs. We
cannot however exclude the role of residues in other motifs since
deletions in the 16–21, 36–42 or 64–70 regions also reduced VLP
production.
With regard to the short cytosolic tail of Gc, a remarkable
ﬁnding was that K2 and K3 play the most critical role in assembly
of VLPs. The reduced production of infectious VLPs displaying
a normal ratio Gc/Gn suggested that a small fraction of particles
were released, the rest remaining in the cells or being eventually
degraded, due to a defect in trafﬁcking of Gc and/or its hetero-
dimerization with Gn. A drastic effect was also observed with
recombinant viruses carrying Gc mutations by perturbing glyco-
proteins localization and intracellular organelles distribution at
the budding site. The viral titer of ZH-Gc-K3A was no more than
1.5% the one of ZH-WT. Despite the low content in glycoproteins
due to the low viral load, the proportion of Gn, Gc and, the N
nucleoprotein was close to wild type ZH suggesting an efﬁcient
encapsidation of the viral genome. More striking was the altered
morphology of cells infected with ZH-Gc-K2A and -K3A and the
distribution of Gn at the cell periphery and into ﬁlopodial exten-
sions. Such alterations are expected to greatly affect particle
budding. The fact that mutating the K2 or K3 residues of the
cytosolic tail of Gc from RVFV led to a mislocalization of Gn at the
cell surface corroborates previous observations related to the Gc-
K3A mutation in the UUKV-VLP model (Overby et al., 2007b). This
supports an additional role of the cytosolic tail of Gc not only for
ER retention, but also for the retention of the Gn/Gc heterodimers
in the Golgi and/or the process of heterodimerization. Reciprocal
interactions might thus be important to target the heterodimer to
the Golgi. This is also substantiated by data indicating that
conformation of Gn/Gc rather than a particular amino acid motif
could be essential for trafﬁcking of hantavirus glycoproteins (Shi
and Elliott, 2002). In addition, some studies have shown that Gn
expressed alone has the capacity to go to the plasma membrane
(Gerrard and Nichol, 2002). The way by which mutations in the di-
lysine motif of Gc may affect Gn/Gc Golgi localization remains to
be determined. This ER retrieval motif (Jackson et al., 1993) is
expected to be buried upon interaction with Gn (Pensiero and Hay,
1992) so that it does not interfere with the Golgi localization of the
heterodimer. However, such retrieval signals should not be func-
tional when adjacent to transmembrane domains (Vincent et al.,
1998), as is the case of the Gc cytosolic tail. A hypothesis could be
that the K2A or K3A mutation interferes with Gc folding and/or
trafﬁcking, leading to no or incorrect assembly with Gn. Alterna-
tively, the mutated Gc could still heterodimerize with Gn, but with
an impact on the structure of Gn cytosolic tail taking over its Golgi
retention signal. Whatever the situation, these two hypotheses are
not exclusive and could lead to altered trafﬁcking and particle
assembly.
An important issue still to be addressed relates to the mode of
interaction of the cytosolic tail of Gc with the cell cytoskeleton as
highlighted by the remodeling of cells infected by the ZH-Gc-K2A
and -K3A mutant viruses. It is well known that RNA viruses use
intracellular membranes of the secretory pathway for their repli-
cation, but underlying mechanisms are poorly understood (Hsu
et al., 2010). The factory built around the Golgi during Bunyam-
wera virus morphogenesis has been 3D reconstructed (Fontana
et al., 2008) and appears to involve different organelles such as ER,
Golgi, mitochondria and other tubular structures. This is consistent
with the fact that Golgi organization depends on actin and
microtubules (Rivero et al., 2009). Accordingly, we found that in
infected cells wild type RVFV envelope glycoproteins mostly
localized at the Golgi apparatus, and that ERGIC redistributed at
the sites of Gn accumulation. The budding of bunyaviruses at other
sites than Golgi (Jantti et al., 1997; Salanueva et al., 2003) even
including the plasma membrane (Anderson and Smith, 1987;
Ravkov et al., 1997) has been reported. In the present study,
cytoskeleton and organelle distributions were altered in wild type
as well as in mutant ZH infected cells but the phenomenon was
greatly exacerbated when K2A or K3A mutation was introduced,
leading to ﬁlopodia formation and cell bridging. This is reminis-
cent of cell projections and networks induced in mosquito cells by
BUNV (Lopez-Montero and Risco, 2011). Our results emphasize
that different modalities may operate in phlebovirus cell propaga-
tion. Actin, microtubules and microﬁlaments are part of the
cytoskeleton network required for virus assembly (Radtke et al.,
2006) and actin manipulation may occur at different steps of viral
infection. Further analysis of Gc-K2A and -K3A mutations could
therefore help to better understand how the cytosolic domains of
the RVFV envelope glycoproteins interact with the cytoskeleton to
allow proper trafﬁcking, assembly and budding of particles and
whether these interactions are direct or indirect through other
viral partners such as Gn or N, or host factors such as protein
components of the cytoskeleton. Actin ﬁlaments have been impli-
cated in hantaviruses morphogenesis (Ravkov et al., 1998) and
have shown to interact with the nucleocapsid of a nairovirus
(Andersson et al., 2004; Ramanathan et al., 2007). We observed
that RVFV viral infection perturbed actin and vimentin but not
tubulin organization. Remarkably, Gn colocalized with vimentin
and the colocalization is complete in the case of Gn-N43A. It is
known that vimentin participate in the building of some viral
factories at the ER-Golgi intermediate compartment (Bhattacharya
et al., 2007; Risco et al., 2002). Vimentin is also implicated in
aggresome formation during virus assembly (Bhattacharyya and
Hope, 2011). It will be important to determine whether bunyavirus
morphogenesis requires some degradation steps.
In conclusion our data point out the implication of speciﬁc
residues of the cytosolic tails of Gn and Gc in RVFV virus
morphogenesis supporting some of the data obtained for UUKV.
They also add new information on the role of the di-lysine motif
commonly found in Gc cytosolic tail of different phleboviruses for
trafﬁcking and cytoskeleton remodeling. The recombinant viruses
produced in this study should be helpful to further explore the
effect of such residues on different aspects of RVFV viral assembly.
Materials and methods
Plasmid constructions
Expression of minigenomes carrying the chloramphenicol
acetyl transferase (CAT) ORF in plasmids pLagCAT, pMagCAT
(ZH548 strain) and pSC13agCAT (Clone 13 strain) has been
previously described (Gauliard et al., 2006). Plasmids, for reverse
genetics expression of the L, M and S segments of ZH548 strain
under the Pol-l promoter, have also been published (Billecocq
et al., 2008). For VLP production, the viral proteins Gn/Gc, N and L
(ZH548 strain) were expressed under the control of the T7
promoter/terminator and EMCV IRES using the pTM1 plasmid.
Gn/Gc ORFs beginning at either the ﬁrst, second or fourth start
codons of the M segment (constructs ATG1, ATG2 and ATG4), were
introduced in pTM1 using the NcoI/XhoI sites. The ATG4 construct
was further used to generate mutants with deletions or single
point mutations in the cytosolic tails of Gn or Gc. Deletions
covering Gn cytosolic tail, i.e.:Δ1–7, Δ8–14, Δ15–21, Δ22–28,
Δ29–35, Δ36–42, Δ43–49, Δ50–56, Δ57–63, and Δ64–70, were
produced using a two-step asymmetric crossover PCR ampliﬁca-
tion and subsequent cloning between the MscI and NsiI sites of the
M segment. Site directed mutagenesis was used to delete the short
cytosolic tail of Gc and produce the Gc cytosolic tail Δ1–5 mutant
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(Quick-Change site directed mutagenesis kit, Stratagene). All point
mutations introducing an alanine replacement in either Gn- or Gc
cytosolic tail were obtained by this same procedure. Cloned
sequences and subsequent mutants were sequenced for the
presence of selected mutations and/or the absence of undesirable
mutations.
Cell culture, transfection and CAT assays
BHK/T7 cells, kindly provided by Naoto Ito (Gifu, Japan), were
grown in Earle's Minimum Essential Medium (Gibco), supplemented
with 5% fetal calf serum (Biowest) and 10% tryptose phosphate broth
(Invitrogen). Vero E6 cells were grown in DMEM (Gibco) supple-
mented with 10% FCS. All media were supplemented with penicillin
at 10 UI/mL, streptomycin at 10 μg/mL and 2 mM L-glutamine
(Invitrogen). BHK/T7 cells were transfected using Fugene6 reagent
(Roche) accordingly to manufacturer instructions. Our ﬁrst screen
revealed that the RVFV L-segment pLagCAT, was the most efﬁcient to
express a CAT reporting activity (data not shown) and was therefore
used to produce minigenome based VLP. A plasmid expressing the
viral glycoproteins under control of the fourth initiating codon was
added to the standard set of plasmids required to reconstitute RNPs
and the viral machinery for minigenome expression, i.e. the viral L
and N proteins and the pLagCAT RNA fragment (Billecocq et al., 2008;
Gauliard et al., 2006).
Supernatant of VLPs producing cells was harvested and VLPs
infectivity monitored on helper cells that were transfected 24 h
prior to infection in order to express the N and L proteins.
Transfected helper cells either infected or not, were used 24 h
post-infection for quantiﬁcation of the CAT reporter gene expres-
sion using the CAT ELISA Kit (Roche) as recommended by the
manufacturer and a Magellan microplate reader (Biorad).
Virus rescue and titration assay
RVFV was rescued by transfecting BHK/T7 cells as described
before (Billecocq et al., 2008). Brieﬂy cells were transfected with
the support plasmids N and L together with the set of the three
pPol-I L, M and S plasmids. Mutations of interest were introduced
in the sequence of Gn or Gc of the full length M fragment. The M
segment was then sequenced to ascertain the presence of the
mutations. Each rescue was performed in triplicate. Pooled culture
medium was collected 3–5 days post-transfection, stored at
 80 1C and used to produce virus stocks by ampliﬁcation on
Vero E6 cells. Vero cells grown in 6 well plates were infected with
serial dilutions of virus seeds and incubated at 37 1C under an
overlay consisting of DMEM, 2% FCS, antibiotics, L-glutamine and
1% agarose. Random clones of the WT and the Gn- and Gc cytosolic
tail mutant viruses were isolated from plaques recovered through
solid medium. This selection was repeated two to three times for
each clone. The presence of the desired mutation was checked by
RT-PCR performed on total RNA extracted from virus-infected cells
with Trizol reagent (Roche), as already described (Billecocq et al.,
2008). Viral titters were determined by counting the lytic plaques
after staining of the infected layer with 0.2% crystal violet in a 10%
formaldehyde and 20% ethanol solution. Working stocks were
prepared by infecting Vero cells at a multiplicity of infection (m.o.
i.) of 0.001. The work with infectious RVFV was carried out under
BSL3 conditions at the Pasteur Institute.
VLPs and virus concentration
Cell culture supernatants were collected 48 h post-transfection
for VLP or 72 h post-infection for virus preparations. Cellular
debris were eliminated by low speed centrifugation (400 g for
10 min at þ4 1C). VLPs were concentrated by ultracentrifugation
(100,000g for 1 h at þ4 1C) through a 20% sucrose (wt/vol)
solution in TN buffer (0.05 M Tris HCl pH7.4, 0.1 M NaCl). Pellets
were recovered and air-dried for 10 min before resuspension for
SDS-PAGE analysis. The same concentration procedure was applied
to viruses isolated from the supernatant of infected cells.
PAGE and Western blotting
VLP or virus samples resuspended in Laemli buffer were run on
10% polyacrylamide gels (Biorad) in non-reducing conditions and
proteins were transferred onto nitrocellulose membranes (Amer-
sham). Membranes were blocked with a solution of 5% milk (low
fat) in PBS containing 0.05% of Tween 20 also used to dilute
antibodies. The 4D4 mouse monoclonal antibody used to detect
Gn and the anti Gc mix (1G4, 4B6 and 1F7 used as a mix) were
kindly provided by Dr. C. Schmaljohn. The N protein was detected
with mouse ascites produced in the laboratory. The immune
detection was performed by incubating the membrane with an
anti-mouse antibody coupled to horseradish peroxidase (Sigma)
then reacted with a chemiluminescent substrate (ECL Pierce/
Thermo Scientiﬁc) and revealed by ﬁlm exposure (Amersham).
Quantiﬁcation of the protein and determination of the ratio
between the glycoproteins and or the nucleocapsid was performed
using the ImageJ software. Viral particles from the ZH548 strain
were used as internal control and exposure time deﬁned in such a
way that the Gc/Gn ratio of this control was approximately 1 and
used as reference for the relative quantiﬁcation of the glycopro-
teins of mutant VLPs.
Immunoﬂuorescence microscopy
BHK-T7 cells were grown on glass coverslips and transfected as
described for VLP production. At 48 h post-transfection, the cells
were ﬁxed for 15 min at 20 1C in methanol, then permeabilized
with 0.5% Triton X100 in PBS for 10 min at room temperature and
saturated with 0.5% BSA in PBS for 30 min. In the case of virus-
infected cells, Vero E6 cells grown 24 h on coverslips in 12 wells
microplates were infected with WT or Gn/Gc mutant viruses at a
m.o.i. of 2. Cells were ﬁxed at 17 h post-infection with formalde-
hyde 3.7% in PBS for 15 min at room temperature. Membrane
immunoﬂuorescence was performed on ﬁxed cells that were
further permeabilized with triton X100 at 0.5% for intracellular
immunolabeling. Antibodies were diluted in PBS containing 1%
BSA and 0.05% Tween and incubated 1 h at room temperature.
In the VLP system, glycoproteins were detected using a mix of
monoclonal antibodies (4D4, 6G4, 4G11 and 3G2). In Vero E6
infected cells, Gn was revealed with the 4D4 monoclonal antibody.
Rabbit polyclonal antibodies anti-Giantin (Abcam), anti-Calnexin
(Stressgen) and anti-ERGIC-53/p58 (Sigma) were used respectively
as markers of the Golgi, the endoplasmic reticulum (ER) and the
ER-Golgi intermediate compartment (ERGIC). In addition we used
speciﬁc rabbit polyclonal antibodies to detect vimentin or tubulin
(Abcam). Alexa Fluor 555- and alexa ﬂuor 488-conjugated goat
anti-mouse or anti-rabbit (Molecular Probes/Invitrogen) as well as
an AMCA-coupled goat anti rabbit antibody (Vector), were used as
secondary antibodies. Phaloïdin directly coupled to texas red
(Invitrogen/Molecular Probe) was used to detect actin. Of note, a
weaker but similar viral glycoprotein distribution was observed
when ﬁxing cells at an earlier time point (6 h post-infection, data
not shown). Imaging was performed with a Zeiss Axiovert 200 M
inverted microscope and Zeiss Axiovision 4.8 software. A series of
grid projection acquisitions allows for optical slice view recon-
struction from ﬂuorescent samples. We beneﬁt from the plateform
facilities at the Imagopole (Institut Pasteur, Paris).
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